Nose-knows: How a Stanford research project turned into a way to fix a deviated septum

Nose knows - close up image of nose
Leaders of a Peninsula medical device startup believe they can straighten out nasal septal deviations for potentially hundreds of thousands of people – bizjournals.com

Nose-knows: How a Stanford research project turned into a way to fix a deviated septum

San Francisco Business Times spoke to CEO Ben Bishop about Spirair’s mission to solve an unmet need in nasal septal deviation (NSD) and nasal airway obstruction (NAO) treatments. The article also delves into the company’s origin story including its roots in the Stanford Biodesign Fellowship and official company launch during the COVID-19 pandemic. In 2021, Spirair secured Series A funding from Sonder Capital and View Ventures to further its R&D efforts in preparation for its first FDA 510(k) clearance for the SeptAlign Implant. Download the full article here.

 

Spirair and its products may be featured by third-party publications. The opinions and comments expressed by a third party are their own. Spirair does not claim any accuracy of third-party reporting. Individual results may vary depending on the patient’s circumstances and condition.

Connect With Us

SEPTALIGN™ Indications for Use: SeptAlign™ is a proprietary bioabsorbable implant used to support and straighten minor deviations in septal cartilage when sufficient healthy cartilage exists and the cartilage is appropriately mobilized using standard septoplasty techniques. Potential adverse reactions are those typically associated with surgically implanted materials, including chronic inflammatory foreign body reaction, infection, septal perforation, and extrusion.

TURBALIGN™ Indications for Use: TurbAlign™ is intended to separate the middle turbinate from the lateral nasal wall during the clinically relevant healing phase associated with sinus surgery (e.g., endoscopic sinus surgery, FESS). The implant provides short-term fixation of the middle turbinate to the nasal septum and thus minimizes the risk of adherence to the lateral wall.

References:

Caution: Federal (USA) law restricts this device to sale by or on the order of a physician.

SPIRAIR®, SEPTALIGN™ and TURBALIGN™ are trademarks of Spirair Inc.

MRK-010-B Copyright © 2025 Spirair, Inc.